+13.1%
GSK vs RPRX
+85.8%
-72.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +1.7% | +3.3% | +4.1% |
| 7D | +4.9% | +4.2% | +0.7% | +2.6% |
| 30D | +9.9% | +19.2% | -9.4% | +0.1% |
| 3M | +0.2% | +18.0% | -17.9% | -8.4% |
| 6M | +2.3% | +35.7% | -33.4% | -12.7% |
| YTD | +7.1% | +77.2% | -70.2% | -16.8% |
| 1Y | +13.1% | +82.0% | -68.9% | -12.4% |
| All | +13.1% | +85.8% | -72.7% | -12.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling